Shah Gautam 4
4 · ACHILLION PHARMACEUTICALS INC · Filed Sep 28, 2012
Insider Transaction Report
Form 4
Shah Gautam
SVP and Chief Compliance Ofc.
Transactions
- Sale
Common Stock
2012-09-27$10.00/sh−7,005$70,050→ 3,125 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2012-09-27−7,005→ 0 totalExercise: $4.82Exp: 2012-09-27→ Common Stock (7,005 underlying) - Exercise/Conversion
Common Stock
2012-09-27$4.82/sh+7,005$33,764→ 10,130 total
Footnotes (1)
- [F1]This option was granted on December 14, 2007 and vested over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.